The Third Circuit ruled in a precedential opinion Tuesday that a Pennsylvania federal judge erred on several grounds in granting summary judgment to GlaxoSmithKline in a lawsuit over the marketing of the diabetes drug Avandia…

Read this piece in its entirety at Law360.